Market Overview

Coherus Biosciences (NASDAQ: CHRS)

18.62 +0.57 (3.16%)

Analyst Ratings

DateResearch FirmActionCurrentPT
11/06/20HC Wainwright & Co.MaintainsBuy32.0
8/10/20Truist SecuritiesMaintainsBuy30.0
8/07/20HC Wainwright & Co.MaintainsBuy33.0
7/16/20B of A SecuritiesInitiates Coverage OnNeutral20.0
4/17/20SunTrust Robinson HumphreyInitiates Coverage OnBuy26.0
2/28/20H.C. WainwrightReiteratesBuy30.0
2/06/20JP MorganMaintainsOverweight35.0
8/13/19MizuhoInitiates Coverage OnBuy43.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter